Anti-SARS-CoV-2 Monoclonal Antibodies for Long COVID (COVID-19) (outSMART-LC)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05877508 |
Recruitment Status :
Active, not recruiting
First Posted : May 26, 2023
Last Update Posted : January 5, 2024
|
Sponsor:
Michael Peluso, MD
Collaborators:
Aerium Therapeutics
Patient-Led Research Collaborative
PolyBio Research Foundation
Information provided by (Responsible Party):
Michael Peluso, MD, University of California, San Francisco
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Estimated Primary Completion Date : | July 31, 2025 |
Estimated Study Completion Date : | July 31, 2025 |